The contract must promise measurable health value without making the program financially ungovernable.
Clinical leadership protects proof of outcomes, while finance protects predictable benefit spend.
Who you’d be doing this for
“My medical team wants evidence, and Finance keeps asking what happens if engagement never shows up.”
Hugo Martin · Director of Care Management
She sponsors the health plan program and must defend its value to clinical and finance leadership.
What is at stake
A 25,000-member program is stalled because clinical and finance leaders reject each other’s pricing model. You must weigh credible outcome proof against terms the health plan can approve and operate.
Why it isn’t already fixed
Every obvious fix costs something else. That’s the part you’d have to decide.
- clinical proof vs predictable benefit spend
- signature speed vs durable contract terms
- member outcomes vs bounded financial exposure
- custom partner demands vs repeatable program economics
Why Ōura
Continuous physiological signals and Membership access make the program valuable only if the health plan can explain both member outcomes and commercial accountability.
Written with these in mind
Not your kind of problem? 30 more at Ōura, or browse every organization.
This is the setup. The work is inside.
Running it puts you in the room: the full situation and its constraints, stakeholders who push back in their own words, and the decisions that are yours to make. What you produce becomes a Day One Plan — work you can show someone instead of describing.